Pages that link to "Q35633839"
Jump to navigation
Jump to search
The following pages link to Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma (Q35633839):
Displaying 50 items.
- Upper urinary tract disease: what we know today and unmet needs (Q26773671) (← links)
- Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract (Q26775097) (← links)
- Why are upper tract urothelial carcinoma two different diseases? (Q28074161) (← links)
- Toward a science of tumor forecasting for clinical oncology (Q35178358) (← links)
- Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature. (Q35180823) (← links)
- The significance of functional renal obstruction in predicting pathologic stage of upper tract urothelial carcinoma (Q35428883) (← links)
- Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis. (Q35690319) (← links)
- Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma (Q38630860) (← links)
- Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates (Q36978225) (← links)
- Perioperative treatments for resected upper tract urothelial carcinoma: a network meta-analysis (Q37709517) (← links)
- Contemporary Evaluation and Management of Upper Tract Urothelial Cancer (Q38724610) (← links)
- A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma. (Q38732900) (← links)
- Prognostic serum markers in patients with high-grade upper tract urothelial carcinoma (Q38861428) (← links)
- Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review. (Q39078873) (← links)
- Optimizing management of upper tract urothelial carcinoma (Q39349303) (← links)
- Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease (Q39865101) (← links)
- The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer (Q40448631) (← links)
- Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy? (Q40671320) (← links)
- Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy (Q40714083) (← links)
- Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy (Q40806274) (← links)
- Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association. (Q40925557) (← links)
- Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent (Q41056921) (← links)
- Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma. (Q47134826) (← links)
- Impact of surgical waiting time on survival in patients with upper tract urothelial carcinoma: A national cancer database study (Q47897828) (← links)
- Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcino (Q47936737) (← links)
- Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study (Q48293327) (← links)
- Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy (Q49414768) (← links)
- The preoperative sarcopenia status is associated with lymphovascular invasion in upper tract urothelial carcinoma patients treated with radical nephroureterectomy (Q49540562) (← links)
- Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study (Q49543774) (← links)
- Urothelial cancer: Optimizing and integrating cisplatin-based chemotherapy across the disease spectrum (Q50042571) (← links)
- Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma. (Q50055581) (← links)
- Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report (Q50317911) (← links)
- Comparison of Single-docking Robotic-assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection During Nephroureterectomy With Bladder Cuff Excision for Upper-tract Urothelial Carcinoma (Q50787360) (← links)
- Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma (Q50857032) (← links)
- Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma. (Q52591360) (← links)
- Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma. (Q52805267) (← links)
- Systemic chemotherapy and radical nephroureterectomy. (Q52951360) (← links)
- Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis. (Q55104185) (← links)
- The prognostic significance of Albumin-to-Alkaline Phosphatase Ratio in upper tract urothelial carcinoma (Q58771450) (← links)
- High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma (Q63966161) (← links)
- High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center (Q64056486) (← links)
- Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts (Q64260619) (← links)
- Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma (Q88344199) (← links)
- Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives (Q89537437) (← links)
- Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial (Q90130833) (← links)
- Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma (Q90744502) (← links)
- Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma (Q91685402) (← links)
- Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma (Q91872503) (← links)
- Down-Grading of Ipsilateral Hydronephrosis by Neoadjuvant Chemotherapy Correlates with Favorable Oncological Outcomes in Patients Undergoing Radical Nephroureterectomy for Ureteral Carcinoma (Q92257162) (← links)
- Consultation on UTUC, Stockholm 2018: aspects of treatment (Q92259183) (← links)